Armata Pharmaceuticals (ARMP) Share-based Compensation (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Share-based Compensation of $11000.0 for Q1 2026, down 98.59% on a YoY basis from $781000.0 in Q1 2025, and up 100.57% sequentially from -$1.9 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Share-based Compensation (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Share-based Compensation data on file, last reported at $11000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 98.59% year-over-year to $11000.0; the trailing twelve-month figure through Mar 2026 stood at -$565000.0 (down 146.16% YoY), and the FY2025 full-year result was $2.1 million, down 19.23% from the prior year.
- Share-based Compensation advanced to $11000.0 in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.7 million in Q3 2025 to a low of -$1.9 million in Q4 2025.
- A 5-year average of $420882.4 and a median of $575000.0 in 2025 frame the typical range for Share-based Compensation.
- Peak annual rise in Share-based Compensation reached 411.49% in 2024, while the deepest fall reached 909.33% in 2024.
- Tracing ARMP's Share-based Compensation over 5 years: stood at $817000.0 in 2022, then plunged by 76.38% to $193000.0 in 2023, then sank by 909.33% to -$1.6 million in 2024, then dropped by 23.69% to -$1.9 million in 2025, then surged by 100.57% to $11000.0 in 2026.
- Business Quant data shows ARMP's Share-based Compensation at $11000.0 in Q1 2026, -$1.9 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | -1.93 Mn |
| Dec 31, 2025 | -1.93 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Sep 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 575,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | -1.56 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Sep 30, 2024 | 670,000.00 |
| Sep 30, 2024 | 670,000.00 |
| Jun 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 534,000.00 |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 193,000.00 |
| Dec 31, 2023 | 193,000.00 |